Institut National de la Santé et de la Recherche Médicale (INSERM), Centre for Research in Epidemiology and Population Health, U1018, Hormones and Cardiovascular Disease, Villejuif, France.
Arterioscler Thromb Vasc Biol. 2011 Jun;31(6):1445-51. doi: 10.1161/ATVBAHA.111.223453. Epub 2011 Mar 31.
A high thrombin generation level has been associated with the risk of venous thrombosis. Whether changes in this biomarker are relevant to arterial disease remains unknown. We investigated the association of thrombin generation with coronary heart disease (CHD) and acute ischemic stroke (AIS) in the elderly.
We used data from the Three-City study, a prospective cohort including 9294 subjects aged >65 years. After 4 years of follow-up, a case-cohort study was established. Using the calibrated automated thrombography method, endogenous thrombin potential and peak height were measured in plasma samples of all CHD and AIS cases and a random sample of 1177 controls. We did not find any significant association between thrombin generation and CHD. In multivariate analyses, high levels of endogenous thrombin potential and peak height were associated with an increased risk of AIS (hazard ratio=1.16 [95% CI, 0.90 to 1.50] and 1.31 [95% CI, 1.01 to 1.69] for a 1 SD increase, respectively). Data also suggested that these associations might be more important in women (hazard ratio=1.55 [95% CI, 1.05 to 2.33] and 1.71 [95% CI, 1.11 to 2.63], respectively) than in men (P for interaction=0.04 and 0.08, respectively).
Thrombin generation emerges as an independent predictor of AIS, particularly in women. Hypercoagulability may have an important role in the pathogenesis of AIS.
高凝血酶生成水平与静脉血栓形成的风险相关。该生物标志物的变化是否与动脉疾病相关尚不清楚。我们研究了凝血酶生成与老年人冠心病(CHD)和急性缺血性脑卒中(AIS)的关系。
我们使用了三城市研究的数据,该前瞻性队列纳入了 9294 名年龄>65 岁的受试者。随访 4 年后,建立了病例-队列研究。使用校准自动化血栓形成法,在所有 CHD 和 AIS 病例及 1177 名随机对照者的血浆样本中测量了内源性凝血酶潜能和峰高。我们没有发现凝血酶生成与 CHD 之间存在任何显著关联。在多变量分析中,内源性凝血酶潜能和峰高升高与 AIS 风险增加相关(危险比分别为 1.16[95%可信区间,0.90 至 1.50]和 1.31[95%可信区间,1.01 至 1.69],每增加 1 个标准差)。数据还表明,这些关联在女性中可能更为重要(危险比分别为 1.55[95%可信区间,1.05 至 2.33]和 1.71[95%可信区间,1.11 至 2.63],分别),而在男性中则不那么重要(交互作用 P 值分别为 0.04 和 0.08)。
凝血酶生成是 AIS 的独立预测因子,尤其是在女性中。高凝状态可能在 AIS 的发病机制中起重要作用。